A Network Pharmacology Approach for Uncovering the Antitumor Effects and Potential Mechanisms of the Sijunzi Decoction for the Treatment of Gastric Cancer

Table 1

Tumor inhibition rate.

Group	TGIV%	TGIW%
Model	—	—
SJZD-L	9.9	7.8
SJZD-H	60.3^##	61.6^##
Urelumab	70.5^##	70.8^##

Note. TGIW% =  (1-Treatment group weight/Model group weight) × 100%; TGIV =  (1-Treatment group RTV/Model group RTV) × 100%; Relative tumor volume (RTV) = V_{21 day}/V_{0 day}, Compared with model group, ^##.